Search for...
Filter search
Facilities
Conditions
Researchers
Home
Menu
Search
Home
About Us
Our Senior Leadership Team
Research and Innovation Strategy
Our location
Our Research
North Manchester General Hospital
MFT-Sponsored Research
Wythenshawe Hospital
COVID-19 Research
Manchester Royal Eye Hospital
Saint Mary’s Hospital
Trafford Hospitals
University Dental Hospital of Manchester
Community Services
Rare Diseases
Royal Manchester Children’s Hospital
Manchester Royal Infirmary
Our Innovation
Strategic Partnerships
Intellectual Property (IP) and Innovation Management Service
Diagnostics and Technology Accelerator
Innovation District
Innovation Hub
Manchester Clinical Data Science Unit
Hepatitis C Operational Delivery Network for Greater Manchester and East Cheshire
Our Facilities & Services
NIHR Manchester BioResource Centre
NIHR Centre for Precision Approaches to Combatting Antimicrobial Resistance
NIHR Manchester Clinical Research Facility
Research Office
Conducting a Phase I/GM trial
NIHR Manchester Biomedical Research Centre
Vocal
Clinical Photography and Medical Illustration
Meeting & Event Facilities
Biobank and Cellular Pathology Research Service
Getting Involved
Personal data and research
Why is research important?
Get involved in research
Useful Information
Performance
News & Events
Contact Us
News & Events Categories
News & Events Categories
All News & Events
NIHR Healthtech Research Centre Emergency and Acute Care
NIHR Manchester Clinical Research Facility
NIHR Manchester Biomedical Research Centre
Blog
Case Studies
Clinical Scientific Services
COVID-19
Industry Engagement
Manchester Royal Eye Hospital
Manchester Royal Infirmary
NHS at 70
North Manchester General Hospital
Nowgen Meeting and Event Facilities
Royal Manchester Children's Hospital
Saint Mary's Hospital
University Dental Hospital of Manchester
Vocal
Wythenshawe, Trafford, Withington and Altrincham
Archive
MFT lupus patient first recruit to NIHR IMID BioResource
Posted: Thursday Oct 22nd 2020
Share...
Share via Facebook
Share via Twitter
Share via Google+
Share via LinkedIn
